Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep;9(9):3394-3397.
doi: 10.21037/jtd.2017.08.45.

The role of sympathectomy in long QT syndrome

Affiliations
Review

The role of sympathectomy in long QT syndrome

Achilleas Antonopoulos et al. J Thorac Dis. 2017 Sep.

Abstract

Long QT syndrome (LQTS) is an uncommon and potentially fatal cardiac channelopathy. Treatment options can be medical with β-blockers or surgical with implantable cardioverter defibrillator (ICD) implantations and left cardiac sympathetic denervation (LCSD). Purpose of this paper is through a literature review to identify the management algorithm and the role of sympathectomy in LQTS.

Keywords: Horner syndrome; Sympathectomy; long QT syndrome (LQTS); video-assisted thoracoscopic surgery (VATS).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Similar articles

Cited by

References

    1. Schwartz PJ, Periti M, Malliani A. The long Q-T syndrome. Am Heart J 1975;89:378-90. 10.1016/0002-8703(75)90089-7 - DOI - PubMed
    1. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation 2009;120:1761-7. 10.1161/CIRCULATIONAHA.109.863209 - DOI - PMC - PubMed
    1. Shimizu W. Clinical impact of genetic studies in lethal inherited cardiac arrhythmias. Circ J 2008;72:1926-36. 10.1253/circj.CJ-08-0947 - DOI - PubMed
    1. Vincent GM, Schwartz PJ, Denjoy I, et al. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures". Circulation 2009;119:215-21. 10.1161/CIRCULATIONAHA.108.772533 - DOI - PubMed
    1. Chockalingam P, Crotti L, Girardengo G, et al. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol 2012;60:2092-9. 10.1016/j.jacc.2012.07.046 - DOI - PMC - PubMed

LinkOut - more resources